IBJNews

Court upholds Lilly patent on cancer drug Alimta

Back to TopCommentsE-mailPrintBookmark and Share

Indianapolis-based Eli Lily and Co. said a federal court judge has upheld a patent protecting one of its best-selling drugs, the cancer treatment Alimta.

A trial on the drug's compound patent, which protects its chemical makeup, started Nov. 8 and ended Monday with a ruling from the U.S. District Court for the District of Delaware, Lilly said. Generic drugmaker Teva Pharmaceuticals Industries Ltd. had challenged the patent, which protects Alimta until July 2016.

Alimita was Lilly's third-best-selling drug in the third quarter, trailing only the antipsychotic Zyprexa and the antidepressant Cymbalta. Revenue from Alimta climbed 21 percent, to $560.3 million, in the quarter, as sales in Japan rose. Alimta rang up $1.64 billion in sales during the first three quarters of 2010.

It was a welcome court win after a difficult few months for Lilly, which is facing a wave of patent expirations in coming years.

In August, a federal judge in New Jersey ruled that the company's method-of-use patent for attention deficit hyperactivity drug Strattera is invalid; Lilly is appealing that decision.  The previous month, a federal appeals court upheld a ruling that invalidated a patent on cancer drug Gemzar, which generates $750 million in U.S. sales each year.

A generic version of Gemzar launched Monday.

Gemzar is the first of several blockbuster Lilly drugs that will see their patents expire by 2013. Generic versions of Zyprexa, Cymbalta, Evista and Strattera could zap nearly half of Lilly's current sales, putting great pressure on the company to find new drugs to take their place.

Alimta is a chemotherapy drug used to treat advanced nonsquamous non-small cell lung cancer and malignant pleural mesothelioma, a cancer that affects the inside lining of the chest cavity.

Lilly said last month its third-quarter profit jumped 38 percent to $1.3 billion, as international sales climbed. But, aside from court challenges, the company also faces patent expirations for some of its key products. That includes Zyprexa next year and Cymbalta in 2013.

Analysts who follow Lilly question how it will make up for the lost revenue. Company leaders have repeatedly expressed confidence in their pipeline of drugs under development, and they also point to growth opportunities in the animal health business and emerging international markets.

 

 

 


 
 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. why oh why does this state continue to elect these people....do you wonder how much was graft out of the 3.8 billion?

  2. i too think this is a great idea. I think the vision and need is there as well. But also agree with Wendy that there may be better location in our city to fulfill this vision and help grow the sports of hockey and figure skating in Indy. Also to help further develop other parts of the city that seem often forgotten. Any of the other 6 townships out side of the three northernmost could benefit greatly from a facility and a vision like this. For a vision that sounds philanthropic, the location is appears more about the money. Would really like to see it elsewhere, but still wish the development the best of luck, as we can always use more ice in the city. As for the Ice growth when they return, if schedules can be coordinated with the Fuel, what could be better than to have high level hockey available to go see every weekend of the season? Good luck with the development and the return of the Ice.

  3. How many parking spaces do they have at Ironworks? Will residents have reserved spaces or will they have to troll for a space among the people that are there at Ruth Chris & Sangiovese?

  4. You do not get speeding ticket first time you speed and this is not first time Mr.Page has speed. One act should not define a man and this one act won't. He got off with a slap on the wrist. I agree with judge no person was injured by his actions. The state was robbed of money by paying too much rent for a building and that money could have been used for social services. The Page family maybe "generous" with their money but for most part all of it is dirty money that he obtained for sources that are not on the upright. Page is the kind of lawyer that gives lawyers a bad name. He paid off this judge like he has many other tine and walked away. Does he still have his license. I believe so. Hire him to get you confiscated drug money back. He will. It will cost you.

  5. I remain amazed at the level of expertise of the average Internet Television Executive. Obviously they have all the answers and know the business inside and out.

ADVERTISEMENT